News & Events

BD Medical-Diabetes Care, a unit of BD (Becton, Dickinson and Company) announced the launch of the BD AutoShield™ Pen Needle in the United States. This unique safety pen needle can be used with all insulin pens and dosers available in the United States, as well as with other drugs available in pens.*

“We are very pleased to be bringing this product to market,” said John Simmons, Vice President, U.S. Sales and Marketing, BD Medical-Diabetes Care. “As a worldwide leader in insulin delivery devices and safety injection products, we felt a need to respond to the growing demand by our customers who are looking to BD to provide a safety pen needle for healthcare workers. This is the latest in a long line of healthcare worker safety products that incorporate our unique BD needle technology.”

BD is a recognized pioneer in injection safety technologies having introduced the world's first safety-engineered syringe in 1988. BD is also a recognized leader in insulin injection technologies and conventional pen needles.

The BD AutoShield Pen Needle offers benefits for patients, healthcare workers, and facilities:

• Facility benefit: The BD AutoShield Pen Needle provides a universal fit. It fits all U.S. insulin pens and dosers, so there is no need to stock multiple types of pen needles.
• Healthcare worker benefit: The BD AutoShield passive needle shielding technology is designed to reduce accidental injuries and ensure compliance without compromising the injection technique.
• Patient benefit: The BD AutoShield Pen Needle, with its broad shield diameter and BD needle technology, is designed to reduce skin pressure to ensure a more comfortable injection.

“Because the use of injection pens in hospitals and other health care settings continues to rise, particularly in the treatment of patients with diabetes, there has been an increase in demand for safety pen needles,” said Simmons. “BD insulin syringes are the brand of choice for U.S. hospitals* and we hope to be their brand of choice for safety pen needles as well.”

BD’s History of Safety

BD offers one of the most complete lines of advanced protection products in the industry, providing nearly 200 products for use in skin injection, sample collection, infusion therapy, surgery, and disposal.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 27,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.